Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 6/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.31 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL407163 | 0.86 | CA2 (0.53) | USP2TSHRCA2CA1MAPK1 | |
| SCHEMBL29190445 | 0.84 | CA2 (0.52) | USP2TSHRCA2CA1MAPK1 | |
| SCHEMBL27689591 | 0.84 | CA2 (0.52) | USP2TSHRCA2CA1MAPK1 | |
| SCHEMBL31042227 | 0.84 | CA2 (0.52) | USP2TSHRCA2CA1MAPK1 | |
| SCHEMBL25763405 | 0.84 | CA2 (0.35) | USP2TSHRCA2CA1MAPK1 | |
| SCHEMBL23009499 | 0.82 | CA2 (0.39) | USP2TSHRCA2CA1MAPK1 | |
| SCHEMBL8826082 | 0.82 | USP2 (0.37) | USP2TSHRCA2CA1MAPK1 | |
| SCHEMBL21802707 | 0.82 | USP2 (0.37) | USP2TSHRCA2CA1MAPK1 | |
| SCHEMBL7710858 | 0.80 | CA2 (0.38) | USP2TSHRCA2CA1MAPK1 | |
| SCHEMBL31252836 | 0.80 | USP2 (0.35) | USP2TSHRCA2CA1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-9111454-A | — | — | None | — | — | JP | disclosed |
| JP-9041144-A | — | — | None | — | — | JP | disclosed |
| US-20230263049-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-17 | — | — | US | disclosed |
| US-20230212207-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-06 | — | — | US | disclosed |
| US-8563685-B2 | Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof | BIOCON LIMITED (IN) | 2013-10-22 | — | — | US | disclosed |
| US-20120021127-A1 | MATERIAL FOR CHEMICAL VAPOR DEPOSITION AND PROCESS FOR FORMING SILICON-CONTAINING THIN FILM USING SAME | ADEKA CORPORATION (JP) | 2012-01-26 | — | — | US | disclosed |
| US-20100216714-A1 | NATRIURETIC COMPOUNDS, CONJUGATES, AND USES THEREOF | JAMES KENNETH D | 2010-08-26 | — | — | US | disclosed |
| US-20100105605-A1 | FATTY ACID FORMULATIONS AND ORAL DELIVERY OF PROTEINS AND PEPTIDES, AND USES THEREOF | RADHAKRISHNAN BALASINGAM | 2010-04-29 | — | — | US | disclosed |
| US-20080207505-A1 | Bna Conjugates and Methods of Use | JAMES KENNETH D | 2008-08-28 | — | — | US | disclosed |
| WO-2006021850-A3 | CVD PRECURSOR SOLUTION USED FOR PRODUCTION OF A THIN FILM COMPRISING A LANTHANIDE SERIES METAL AND A THIN FILM PRODUCING METHOD USING THE SAME | TOSHIMA MFG CO LTD (JP) | 2006-10-26 | — | — | WO | disclosed |
| WO-2006021850-A2 | CVD PRECURSOR SOLUTION USED FOR PRODUCTION OF A THIN FILM COMPRISING A LANTHANIDE SERIES METAL AND A THIN FILM PRODUCING METHOD USING THE SAME | TOSHIMA MFG. CO. LTD. (JP) | 2006-03-02 | — | — | WO | disclosed |
| WO-2006021850-A2 | CVD PRECURSOR SOLUTION USED FOR PRODUCTION OF A THIN FILM COMPRISING A LANTHANIDE SERIES METAL AND A THIN FILM PRODUCING METHOD USING THE SAME | TOSHIMA MFG. CO. LTD. (JP) | 2006-03-02 | — | — | WO | disclosed |
| JP-H09111454-A | CALCIUM SOURCE MATERIAL FOR CVD AND FILM FORMING METHOD USING THE SAME | DOWA MINING CO LTD | 1997-04-28 | — | — | JP | disclosed |
| JP-H0941144-A | SOURCE MATERIAL FOR CVD OF RARE EARTH ELEMENT AND FILM FORMING METHOD USING THE SAME | DOWA MINING CO LTD | 1997-02-10 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080207505-A1 | Bna Conjugates and Methods of Use | NPR1, NPPA, NPR3 | USP2 4180/4885TSHR 327/4885CA2 2864/4885 |
| US-20100105605-A1 | FATTY ACID FORMULATIONS AND ORAL DELIVERY OF PROTEINS AND PEPTIDES, AND USES THEREOF | FABP2, SLC27A1, SLC27A2 | USP2 2951/4885TSHR 1755/4885CA2 719/4885 |
| US-20230212207-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OTC, OCIAD1 | USP2 4063/4885TSHR 4384/4885CA2 4769/4885 |
| US-20100216714-A1 | NATRIURETIC COMPOUNDS, CONJUGATES, AND USES THEREOF | NPR1, NPPA, NPR3 | USP2 4311/4885TSHR 261/4885CA2 3827/4885 |
| US-20120021127-A1 | MATERIAL FOR CHEMICAL VAPOR DEPOSITION AND PROCESS FOR FORMING SILICON-CONTAINING THIN FILM USING SAME | GRIA4, GRIN2C, NR1H3 | USP2 1489/4885TSHR 2321/4885CA2 2166/4885 |
| US-20230263049-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBPL3, OCIAD1, OSBP | USP2 4825/4885TSHR 1781/4885CA2 4118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.